{"count": 9, "results": [{"_id": "11879715", "pmid": 11879715, "title": "Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia.", "journal": "Diabetes Res Clin Pract", "authors": ["Sen K", "Misra A", "Kumar A", "Pandey RM"], "date": "2002-04-01T00:00:00Z", "doi": "10.1016/s0168-8227(01)00341-2", "meta_date_publication": "2002 Apr", "meta_volume": "56", "meta_issue": "1", "meta_pages": "1-11", "score": 50063.895, "text_hl": "The aim of the present study was to compare the HMG-CoA Reductase Inhibitor, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, with placebo in @SPECIES_9606 @@@patients@@@ having @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@DR@@@ in a double-blind randomized placebo-controlled trial. ", "citations": {"NLM": "Sen K, Misra A, Kumar A, Pandey RM. Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Res Clin Pract. 2002 Apr;56(1):1-11. PMID: 11879715", "BibTeX": "@article{11879715, title={Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia.}, author={Sen K and Misra A and Kumar A and Pandey RM}, journal={Diabetes Res Clin Pract}, volume={56}, number={1}, pages={1-11}}"}}, {"_id": "27084086", "pmid": 27084086, "title": "Simvastatin use associated with low intraocular ADP levels in patients with sight-threatening diabetic retinopathy.", "journal": "Graefes Arch Clin Exp Ophthalmol", "authors": ["Tuuminen R", "Yegutkin GG", "Jalkanen S", "Loukovaara S"], "date": "2016-08-01T00:00:00Z", "doi": "10.1007/s00417-016-3349-3", "meta_date_publication": "2016 Aug", "meta_volume": "254", "meta_issue": "8", "meta_pages": "1643-1644", "score": 50063.336, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ use associated with low intraocular @CHEMICAL_Adenosine_Diphosphate @CHEMICAL_MESH:D000244 @@@ADP@@@ levels in @SPECIES_9606 @@@patients@@@ with sight-threatening @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@diabetic retinopathy@@@.", "citations": {"NLM": "Tuuminen R, Yegutkin GG, Jalkanen S, Loukovaara S. Simvastatin use associated with low intraocular ADP levels in patients with sight-threatening diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2016 Aug;254(8):1643-1644. PMID: 27084086", "BibTeX": "@article{27084086, title={Simvastatin use associated with low intraocular ADP levels in patients with sight-threatening diabetic retinopathy.}, author={Tuuminen R and Yegutkin GG and Jalkanen S and Loukovaara S}, journal={Graefes Arch Clin Exp Ophthalmol}, volume={254}, number={8}, pages={1643-1644}}"}}, {"_id": "20939802", "pmid": 20939802, "title": "Fibrates and statins in the treatment of diabetic retinopathy.", "journal": "Curr Pharm Biotechnol", "authors": ["Ansquer JC", "Crimet D", "Foucher C"], "date": "2011-03-01T00:00:00Z", "doi": "10.2174/138920111794480570", "meta_date_publication": "2011 Mar 1", "meta_volume": "12", "meta_issue": "3", "meta_pages": "396-405", "score": 50063.215, "text_hl": "In the ACCORD-EYE study, the combination of @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ reduced by 40% the rate of progression of @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@diabetic retinopathy@@@ compared with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ alone. ", "citations": {"NLM": "Ansquer JC, Crimet D, Foucher C. Fibrates and statins in the treatment of diabetic retinopathy. Curr Pharm Biotechnol. 2011 Mar 1;12(3):396-405. PMID: 20939802", "BibTeX": "@article{20939802, title={Fibrates and statins in the treatment of diabetic retinopathy.}, author={Ansquer JC and Crimet D and Foucher C}, journal={Curr Pharm Biotechnol}, volume={12}, number={3}, pages={396-405}}"}}, {"_id": "23059402", "pmid": 23059402, "title": "Simvastatin increases circulating endothelial progenitor cells and reduces the formation and progression of diabetic retinopathy in rats.", "journal": "Exp Eye Res", "authors": ["Zhang W", "Yan H"], "date": "2012-12-01T00:00:00Z", "doi": "10.1016/j.exer.2012.09.014", "meta_date_publication": "2012 Dec", "meta_volume": "105", "meta_issue": "", "meta_pages": "1-8", "score": 50062.113, "text_hl": "This study aimed to observe the effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on EPC mobilization, which could alter the rate of @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@diabetic retinopathy@@@ (@<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@DR@@@) formation and progression. ", "citations": {"NLM": "Zhang W, Yan H. Simvastatin increases circulating endothelial progenitor cells and reduces the formation and progression of diabetic retinopathy in rats. Exp Eye Res. 2012 Dec;105():1-8. PMID: 23059402", "BibTeX": "@article{23059402, title={Simvastatin increases circulating endothelial progenitor cells and reduces the formation and progression of diabetic retinopathy in rats.}, author={Zhang W and Yan H}, journal={Exp Eye Res}, volume={105}, pages={1-8}}"}}, {"_id": "18378570", "pmid": 18378570, "title": "Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.", "journal": "Invest Ophthalmol Vis Sci", "authors": ["Al-Shabrawey M", "Bartoli M", "El-Remessy AB", "Ma G", "Matragoon S", "Lemtalsi T", "Caldwell RW", "Caldwell RB"], "date": "2008-07-01T00:00:00Z", "doi": "10.1167/iovs.08-1754", "meta_date_publication": "2008 Jul", "meta_volume": "49", "meta_issue": "7", "meta_pages": "3231-8", "score": 50061.68, "text_hl": "CONCLUSIONS: These results suggest that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ protects against the early signs of @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@diabetic retinopathy@@@ by preventing NADPH oxidase-mediated activation of @GENE_STAT3 @GENE_25125 @@@STAT3@@@.", "citations": {"NLM": "Al-Shabrawey M, Bartoli M, El-Remessy AB, Ma G, Matragoon S, Lemtalsi T, Caldwell RW, Caldwell RB. Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy. Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3231-8. PMID: 18378570", "BibTeX": "@article{18378570, title={Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.}, author={Al-Shabrawey M and Bartoli M and El-Remessy AB and Ma G and Matragoon S and Lemtalsi T and Caldwell RW and Caldwell RB}, journal={Invest Ophthalmol Vis Sci}, volume={49}, number={7}, pages={3231-8}}"}}, {"_id": "15111316", "pmid": 15111316, "title": "Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes.", "journal": "Am J Pathol", "authors": ["Miyahara S", "Kiryu J", "Yamashiro K", "Miyamoto K", "Hirose F", "Tamura H", "Katsuta H", "Nishijima K", "Tsujikawa A", "Honda Y"], "date": "2004-05-01T00:00:00Z", "doi": "10.1016/S0002-9440(10)63728-5", "meta_date_publication": "2004 May", "meta_volume": "164", "meta_issue": "5", "meta_pages": "1697-706", "score": 50056.152, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ may thus be useful in the prevention of @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@diabetic retinopathy@@@.", "citations": {"NLM": "Miyahara S, Kiryu J, Yamashiro K, Miyamoto K, Hirose F, Tamura H, Katsuta H, Nishijima K, Tsujikawa A, Honda Y. Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes. Am J Pathol. 2004 May;164(5):1697-706. PMID: 15111316", "BibTeX": "@article{15111316, title={Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes.}, author={Miyahara S and Kiryu J and Yamashiro K and Miyamoto K and Hirose F and Tamura H and Katsuta H and Nishijima K and Tsujikawa A and Honda Y}, journal={Am J Pathol}, volume={164}, number={5}, pages={1697-706}}"}}, {"_id": "28089735", "pmid": 28089735, "title": "Effects of simvastatin on CAT-1-mediated arginine transport and NO level under high glucose conditions in conditionally immortalized rat inner blood-retinal barrier cell lines (TR-iBRB).", "journal": "Microvasc Res", "authors": ["Tun T", "Kang YS"], "date": "2017-05-01T00:00:00Z", "doi": "10.1016/j.mvr.2017.01.002", "meta_date_publication": "2017 May", "meta_volume": "111", "meta_issue": "", "meta_pages": "60-66", "score": 50047.043, "text_hl": "Thus, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ might be a good modulator for @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@diabetic retinopathy@@@ therapy by increasing of the @CHEMICAL_Arginine @CHEMICAL_MESH:D001120 @@@l-arginine@@@ uptake and improving endothelial function in retinal capillary endothelial cells.", "citations": {"NLM": "Tun T, Kang YS. Effects of simvastatin on CAT-1-mediated arginine transport and NO level under high glucose conditions in conditionally immortalized rat inner blood-retinal barrier cell lines (TR-iBRB). Microvasc Res. 2017 May;111():60-66. PMID: 28089735", "BibTeX": "@article{28089735, title={Effects of simvastatin on CAT-1-mediated arginine transport and NO level under high glucose conditions in conditionally immortalized rat inner blood-retinal barrier cell lines (TR-iBRB).}, author={Tun T and Kang YS}, journal={Microvasc Res}, volume={111}, pages={60-66}}"}}, {"_id": "24506800", "pmid": 24506800, "title": "Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment.", "journal": "Acta Ophthalmol", "authors": ["Tuuminen R", "Sahanne S", "Loukovaara S"], "date": "2014-11-01T00:00:00Z", "doi": "10.1111/aos.12363", "meta_date_publication": "2014 Nov", "meta_volume": "92", "meta_issue": "7", "meta_pages": "675-81", "score": 50046.85, "text_hl": "These data provide a novel insight into the potential protective mechanisms underlying @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ medication in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@diabetic retinopathy complications@@@.", "citations": {"NLM": "Tuuminen R, Sahanne S, Loukovaara S. Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment. Acta Ophthalmol. 2014 Nov;92(7):675-81. PMID: 24506800", "BibTeX": "@article{24506800, title={Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment.}, author={Tuuminen R and Sahanne S and Loukovaara S}, journal={Acta Ophthalmol}, volume={92}, number={7}, pages={675-81}}"}}, {"_id": "21942979", "pmid": 21942979, "title": "Fenofibrate: a review of its use in dyslipidaemia.", "journal": "Drugs", "authors": ["McKeage K", "Keating GM"], "date": "2011-10-01T00:00:00Z", "doi": "10.2165/11208090-000000000-00000", "meta_date_publication": "2011 Oct 1", "meta_volume": "71", "meta_issue": "14", "meta_pages": "1917-46", "score": 50039.566, "text_hl": "However, the risk of some nonfatal macrovascular events and the incidence of certain microvascular outcomes were reduced significantly more with @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ than with placebo in the FIELD trial, and in the ACCORD trial, @SPECIES_9606 @@@patients@@@ receiving @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ plus @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ were less likely to experience progression of @<m>DISEASE_Diabetic_Retinopathy</m> @DISEASE_MESH:D003930 @@@diabetic retinopathy@@@ than those receiving @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ plus placebo. ", "citations": {"NLM": "McKeage K, Keating GM. Fenofibrate: a review of its use in dyslipidaemia. Drugs. 2011 Oct 1;71(14):1917-46. PMID: 21942979", "BibTeX": "@article{21942979, title={Fenofibrate: a review of its use in dyslipidaemia.}, author={McKeage K and Keating GM}, journal={Drugs}, volume={71}, number={14}, pages={1917-46}}"}}]}